Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05128799 · ClinicalTrials.gov registry record
Effect of the 3 Wishes Program on Bereaved Families' End-of-Life Care Perceptions
A clinical trial, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 314
- Enrollment target
NCT05128799: Completed study, sponsored by University of California, Los Angeles.
NCT05128799 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 314 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05128799 has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 314 participants
- Enrollment target
Study Summary
Dying in the intensive care unit (ICU) can be a source of trauma for patients and their families. The 3 Wishes Program is a palliative care initiative in which healthcare workers fulfills small wishes to provide a personalized, humanizing experience at the end of life (EOL) for dying patient and their families. The investigators' objective is to assess families' ratings of EOL care for ICU decedents who received the 3WP as part of their EOL care versus usual care.
Primary Outcome
Emotional and spiritual support factor score on the Bereaved Family Survey total score ranges 0-9 (higher is better)
Interventions
- OTHER 3 Wishes Program (3WP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 314 participants |
| Start Date | 2019-10-08 |
| Est. Completion | 2021-11-09 |
What the finished NCT05128799 record still lists
NCT05128799 is an observational study that tracks outcomes without assigning an intervention. The registered 314 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which 3 Wishes Program (3WP) is the first listed.
NCT05128799 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05128799 about?
NCT05128799 is a clinical study titled "Effect of the 3 Wishes Program on Bereaved Families' End-of-Life Care Perceptions". Dying in the intensive care unit (ICU) can be a source of trauma for patients and their families. The 3 Wishes Program is a palliative care initiative in which healthcare workers fulfills small wishes to provide a personalized, humanizing experience at the end of life (EOL) for dying patient and the...
What is the current status of trial NCT05128799?
This trial is currently completed. The enrollment target is 314 participants. The study started on 2019-10-08. Estimated completion is 2021-11-09.
What interventions are being tested in trial NCT05128799?
The interventions under investigation include: 3 Wishes Program (3WP) (OTHER).
Who is sponsoring clinical trial NCT05128799?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03866382 · 314 participants · Phase 2
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- NCT04500756 · 314 participants · Phase 2
Limiting AAA With Metformin (LIMIT) Trial
- NCT06167746 · 314 participants · Phase 3
iCare4Me Transitions
- NCT06883097 · 314 participants · NA
Quitting Matters Human Immunodeficiency Virus Hybrid Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI